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Background/aim: The objective of this experimental study was to examine the effects of epinephrine, dexmedetomidine, and clonidine
added as adjuvants to bupivacaine on block onset and effect times, as well as the effects on the Na+ and Ca+2 channel gene expressions,
which may indicate cell damage in the sciatic nerve cell membrane.
Materials and methods: Rats were divided into five groups: Group S (sham), saline solution; Group B, bupivacaine; Group BD,
bupivacaine + dexmedetomidine; Group BC, bupivacaine + clonidine; and Group BE, bupivacaine + epinephrine. For each group, 0.2
mL of local anesthetic was injected into the sciatic nerve bifurcation point of the right leg. Sensory (proprioceptive and nociceptive
block) and motor block onset and ending times were recorded.
Results: The shortest onset time for the examined sciatic block was observed in the BC group, whereas the longest sensory and motor
block times were observed in the BD group. The present data suggest suppressed TRPM7 and increased TRPM2 in the groups other
than the BE group.
Conclusion: Clonidine is more suitable for fast onset of peripheral nerve blocks, whereas the addition of dexmedetomidine is better in
terms of duration. Because the SCN9A and TRPM2,4,7 expression ratios of the BE group showed the least amount of change, this group
had the best cellular integrity.
Key words: Sciatic nerve block, bupivacaine, TRPM, rat

1. Introduction
The sciatic nerve block is a regional anesthetic method that
provides muscle relaxation and pain control in knee and
foot surgery and has a low risk of local anesthetic toxicity.
The use of peripheral nerve blocking has increased in line
with developments in algology. Therefore, the need for
long effect agents with low neurotoxic effects has grown.
Bupivacaine is a local anesthetic that has a more prolonged
effect, is more successful compared with other local
anesthetics, and is less expensive (1).
The frequent use of regional anesthetic has precipitated
an increase in the use of adjuvant agents added to local
anesthetics to decrease the effect onset time while
increasing the duration and quality of the block. There are
many studies in which agents such as opioids, a1-2 agonists,
and NaHCO3 have been used. However, we found no study
* Correspondence: dskaplan@gantep.edu.tr
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that compares the sensory and motor block duration
of bupivacaine with the addition of dexmedetomidine,
epinephrine, and clonidine as adjuvants.
Voltage-gated sodium channels are expressed
at different levels in the central nervous system, the
peripheral nervous system, and muscle cells based on
development and take part in important mechanisms such
as the onset and transfer of action potential. It has also
been suggested that TRP channels play an important role
in the mechanism of calcium as a second messenger (2),
that they are sensitive to cellular death in many cellular
functions (3), that they are related to cation flow in
unexcited cells and are effective in calcium permeability
(4), that they are generally independent of voltage (5),
and that they have many functions related to cellular
proliferation, fertility, and the sense of touch (6). The
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members of the TRPM family are divided into four groups:
TRPM 1–3, TRPM 2–8, TRPM 4–5, and TRPM 6–7
(4,7–11). TRPM channels have high cation permeability,
ranging from high Ca+2 and Mg+2 permeabilities (TRPM
6–7) to Ca+2 impermeability. TRPM2 channels are located
in the brain and are nonselective Na+, Ca+2, K+, and Cl+
permeable channels. TRMP2 is activated by H2O2 and acts
as a cellular redox sensor. It also plays an important role in
oxidative stress, TNFα-mediated Ca+2 intake, and cellular
death (12–14). TRPM4 is found in high amounts in the
heart, pancreas, and placenta. TRPM4 and TRPM5 are
permeable to monovalent cations but impermeable to Ca+2
(15). TRPM7 is nonselectively Na+ and Ca+2 permeable
and is also important in attaining intracellular Mg+2
homeostasis. The decrease in intracellular Mg+2 in the case
of TRPM7 insufficiency shows that TRPM7 plays a role in
Mg+2 intake and homeostasis (16,17).
The objective of the present study was to compare
the block onset and effect times of bupivacaine, which is
one of the most commonly used local anesthetics, with
those of epinephrine, dexmedetomidine, and clonidine,
which are added to bupivacaine as adjuvants. Another
objective was to examine their effects on Na+ and Ca+2
channel gene expressions, which may indicate cell damage
after anesthesia in the sciatic nerve cell membrane, in the
groups in this study.
2. Materials and methods
This study was carried out at the Gaziantep University
Physiology Department Experimental Animals Research
Laboratory with approval number 2011/53-3 from the
Gaziantep University Faculty of Medicine Ethics Council.
2.1. Animals
A total of 30 mature, healthy male Wistar albino rats with
weights ranging between 200 and 250 g were used in
this study. The rats were held in an environment with a
moisture ratio of 50%–60% at an ambient temperature of
24–26 °C in circadian rhythm with 12 h of light and 12 h
of darkness. Standard commercial pellet feed and city tap
water were used to feed the rats. No change was made in
their feeding habits. Daily close monitoring of the rats was
performed for 15 days prior to the study. The reason for
this was to ensure that the rats got used to the researcher
who was going to carry out the neurological and behavioral
examination, the experiment environment, and the
experiment methods such as the neurological evaluation.
The aim of this adaptation period was to minimize stress
during the experiment and thus to increase experiment
performance. Focus was on the rear extremity of the rat
for a correct neurological evaluation.
2.2. Doses and groups
Bupivacaine (Marcaine, 0.5%, Astra Zeneca, Kırklareli,
Turkey) was used as a local anesthetic, whereas

dexmedetomidine (Precedex 100 µg/mL, Abbott, Chicago,
IL, USA), clonidine (Clonidin-Ratiopharm 0.15 mg/mL,
Ratiopharm, Blaubeuren, Germany), and epinephrine
(Adrenalin 0.5 mg/mL, Osel, İstanbul, Turkey) were used
as adjuvants.
The subjects were divided into 5 groups with 6 rats in
each group. A total of 0.2 mL solution 27 gauge needle
point injectors were prepared for each rat in the five groups
blinded to surgeons. The groups were as follows:
Group (S): sham, (physiological saline solution)
Group (B): bupivacaine (5 mg/mL)
Group (BD): bupivacaine (5 mg/mL) +
dexmedetomidine (0.005% (5 µg/mL))
Group (BC): bupivacaine (5 mg/mL) + clonidine
(0.00075% (7.5 µg/ml))
Group (BE): bupivacaine (5 mg/mL) + epinephrine
(0.0005% (5 µg/mL))
2.3. Surgical procedure
The rats were anesthetized with a 5 mg/kg intraperitoneal
ketamine (Ketalar, 50 mg/mL, Pfizer, İstanbul, Turkey)
injection. The trochanter major and ischial tuberosity
were marked on the right legs with a posterior approach.
The area between the marked points was shaved, after
which a lateral subcutaneous incision was made and the
surface fascia and muscles were excluded. All injections
(local anesthetics) were given after full recovery from the
ketamine anesthesia so that the block onset times could
be evaluated. The 0.2 mL of local anesthetic that was
prepared previously was injected under the epineurium
without damaging the nerve integrity at the proximal of
the sciatic nerve bifurcation point (Figure 1A). The surface
muscle plans were brought closer and 4/0 silk was used for
suturing. The skin was sutured with 3/0 silk (Figure 1B).
2.4. Experimental strategy
A double blind, randomized, controlled experimental
model was used to evaluate motor and sensory blocks.
The rats and the local anesthetic solutions were assigned
unique identification numbers, to which the investigators
were blinded. The same experiment row was used for
the motor and sensory evaluations. Proprioceptive tests
were carried out first, followed by motor evaluation and
nociceptive tests. The opposite extremities of the rats were
used as controls to evaluate channel expressions. The
block evaluation was carried out as either available (+) or
not available (–), without taking into account the block
intensity.
2.5. Proprioceptive sensory function
Proprioceptive and nociceptive sensory evaluation and
motor function were evaluated as described previously by
Estebe and Thalhammer et al. (18,19). The proprioceptive
sensory evaluation was carried out in a resting posture, and
postural reactions (tactile placing response and hopping
response) were observed. The tactile placing response was
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Figure 1. The 0.2 mL local anesthetic injection under the epineurium at the proximal of the sciatic nerve bifurcation
point (A). The skin suture with 3/0 silk (B).

evaluated based on the ability of the rats to bring their
paws back to the original position after flexing the paw in
a normal resting position until the dorsal surfaces touched
the ground. The front half of the rat was lifted up from
the surface in order to evaluate the hopping response.
One hind leg at a time was lifted off the ground, and the
animal’s body moved laterally. As soon as this happens, an
animal normally hops with the weight bearing limb in the
direction of movement to avoid falling over. If the motor
block is stronger, a rapid but weaker hopping response is
observed right after the onset of the lateral movement.
In contrast, if the proprioceptive block is stronger, then
the hopping response is delayed and the passive lateral
movement required to induce hopping should be wider.
2.6. Motor function
Motor function was evaluated based on the rats putting
their weight on the rear foot, their hopping ability, their
ability to grasp with their paw when hung upside down by
their tails, and their ability to walk.
2.7. Nociceptive sensory function
The nociceptive sensory evaluation was carried out
according to the flexor reflex of the rat. The flexor reflex
occurs by the contraction of the flexor muscles in the hip,
knee, and ankle. It is a polysynaptic reflex and is induced
by giving a painful stimulant to the extremity. The intensity
and duration of the flexor reflex depend on the intensity of
the painful stimulant applied. The painful stimulant was
applied mechanically in the study. Pressure was applied to
the skin fold on the lateral metatarsus for surface sensation
of pain, whereas pressure was applied to the distal phalanx
of the fifth toe via tissue forceps for deep sensation of pain.
A single painful stimulant was applied to the predefined
regions by the same researcher at the same intensity and
for the same duration of time.

928

2.8. RNA isolation and cDNA synthesis
Sciatic nerve samples were acquired from both legs of the
rat for genetic evaluation following the process. Tissues
were stored at –80 °C for RT-PCR studies. A Qiagen
TissueLyser (Catalogue no 85600, Poison Information
Center Mainz, Germany) device and Qiazol lysis reagent
kit were used for tissue disruption and homogenization
during the RNA isolation stage. A Roche high pure RNA
tissue kit (Catalogue No. 12 033 674 001, Mannheim,
Germany) was used for the isolation stage. RNA isolation
was carried out in accordance with the directions provided
by the manufacturing company.
A Biolabs Kit was used in accordance with the
directions provided by the manufacturing company for
cDNA synthesis. The reaction was prepared as shown
below for cDNA synthesis with a total volume of 20 μL
and cDNA synthesis was carried out under the following
conditions: d(T)23VN (50 µM) (2 μL), RNase free water
(5 μL), RNA (2 μL), AMV reaction mix (10 μL), AMV
enzyme mix (2 μL).
2.9. Reverse-transcriptase PCR (RT-PCR)
Optimum PCR conditions for each gene region were
determined prior to the RT-PCR stage taking into
consideration the GC % and Tm (melting temperature),
obtained as a result of the design of the primers of the
genes to be analyzed, as well as the base length values of
the genes. The gradient PCR stage carried out to determine
the optimum conditions was executed via Corbett
Research (Model: RG-600, Australia). The PCR conditions
determined for each gene were realized via Applied
Biosystem Geneamp PCR system 9700 PCR device. The
denaturation operation for the obtained cDNAs was
carried out under the PCR conditions determined as
follows: 2 min at 94 °C (for β-actin housekeeping gene), for
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4 min at 94 °C (TRPM2), and for 5 min at 94 °C (TRPM4,
TRPM7, SCN9A); the 2nd denaturation stage was carried
out for 30 s at 94 °C (for all genes); the binding stage was
carried out for 45 s at 60 °C (β-actin, TRPM2), for 30 s at
60 °C (TRPM4), for 30 s at 60.4 °C (TRPM7), and for 30 s
at 62.4 °C (SCN9A); the elongation stage was carried out
for 30 s at 72 °C (for all genes); and the final elongation
stage was carried out for 2 min at 72 °C (β-actin) and for 5
min at 72 °C (TRPM2, TRPM4, TRPM7, SCN9A).
The PCR products of the gene regions of all sample
groups were run over 2% agarose gel at the end of RTPCR (Figure 2). The gel images acquired as a result of
electrophoresis were transferred to the digital environment.
Image J software was used to measure the expressions
levels of the studied genes.
The gene expression levels of TRPM2, TRPM4, TRPM7,
and SCN9A were compared with the beta-actin gene as
well as cDNA light brightness level.
2.10. Evaluation of results
The nerve tissues of the same rats (tissues with block
and normal tissues) were compared with one another
and studied simultaneously during the study. Beta-actin,
which was used as a housekeeping gene, was studied as
RT-PCR in the same sample. mRNA expression value was
calculated by placing the measurement values obtained
for each gene (SCN9A, TRPM2, TRPM4, TRPM7) in the
following formula. Normal (0.75–1.25), low (0–0.75), and
high (>1.25) parameters were used for the evaluation of
the acquired results.

mRNA
expression value =

Blocked gene expression /
Normal geneexpression
Blocked β-actin / normal β-actin

2.11. Statistical method
SPSS 11.5 was used for the evaluation of the data about
block times. One-way variance analysis (one way ANOVA)
and Tukey HSD of the post hoc tests were used for the
evaluation of the differences between groups since the
groups displayed normal distribution. The values were
given as average ± standard deviation. Values of P < 0.05
were accepted as statistically significant.
3. Results
No proprioceptive, motor, or nociceptive block developed
in the counter extremities following the local anesthetic
injections to the sciatic nerve in the rats of the 5 groups
included in the study. In addition, no proprioceptive,
motor, or nociceptive block developed in the Sham (S)
group following injection, for which saline solution
was used. Therefore, the Sham group indicated that our
injection under the epineurium did not damage nerve
integrity. Nociceptive block onset times were taken as
the basis when recording the block onset times since
the proprioceptive, motor, and nociceptive times were
very close to each other. The block onset times and the
proprioceptive, motor, and nociceptive block durations
are given in the Table.

Figure 2. Gel electrophoresis image of the Na+ channel gene SCN9A expression measurements. B (Group 2), B+D (Group 3), B+C
(Group 4), B+A (Group 5), B: Sciatic nerve with block, N: Normal (sciatic nerve without block).
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Table. The block onset and end times of groups (mean ± standard deviation (SD)).
Groups

Group B
(n = 6)

Group BD
(n = 6)

Group BC
(n = 6)

Group BE
(n = 6)

Block onset time (s)

288 ± 35.87

168 ± 31.41*

115 ± 13.19*#

162 ± 30.78*

Proprioceptive block durations (min)

82 ± 21.77

131 ± 17.15*

105 ± 5.4

117 ± 7.3*

Motor block durations (min)

84 ± 20.03

124 ± 16.57*

91 ± 13.62

113 ± 7.79*

Nociceptive block durations (min)

144 ± 18.20

266 ± 23.89*

176 ± 14.44*#

183 ± 14.37*#

#

#

(*): Statistically significant compared to group B (P < 0.05) (#): Statistically significant compared to group BD (P < 0.05)

The block onset times were respectively as follows
BC < BE < BD < B, whereas the block end order was
proprioceptive, motor, and nociceptive in the B group; it
was motor, proprioceptive, and nociceptive block for the
BD, BC, and BE groups. Accordingly, the fastest block
onset time was that of the BC group and the longest block
time was that of the BD group.
A statistically significant decrease was observed in the
block onset times in all groups with adjuvant addition in
comparison with the group to which pure bupivacaine
was administered (P < 0.001). A statistically significant
decrease in duration was also observed in the group to
which clonidine (P = 0.025) was added as adjuvant in
comparison with the group to which dexmedetomidine
was added (Figure 3).
The proprioceptive block durations were determined
to be longer at a statistically significant level for the group
to which dexmedetomidine (P < 0.001) and epinephrine (P
= 0.002) were added as adjuvants in comparison with the
group to which pure bupivacaine was added. The increase
in the proprioceptive block duration was not statistically
significant in the group to which clonidine (P = 0.051)
was added in comparison with the group to which pure
bupivacaine was administered. The proprioceptive block
duration of the dexmedetomidine (P = 0.029) added group

300

Bloc k onset time
288

Time (sec)

250
200

168*

150

162*
115*#

100
50
0

Group B

Group BD

Group BC

Group BE

Figure 3. Block onset time of groups. (*): Statistically significant
compared to group B (P < 0.05), (#): Statistically significant
compared to group BD (P < 0.05).

930

Time (min)

350

was longer at a statistically significant level in comparison
with the group to which clonidine was added (Figure 4).
The motor block durations were determined to be
longer at a statistically significant level in groups to which
dexmedetomidine (P = 0.001) and epinephrine (P = 0.019)
were added as adjuvants in comparison with the group
to which pure bupivacaine was added. No statistically
significant elongation in the motor onset duration was
determined for the group to which clonidine (P = 0.854)
was added in comparison with the group to which pure
bupivacaine was added. Dexmedetomidine (P = 0.006)
also increased the motor block duration at a statistically
significant level in comparison with clonidine (Figure 5).
The nociceptive block duration for the groups to
which adjuvants were added increased at a statistically
significant level in comparison with the group to which
pure bupivacaine was added (BD; P < 0.001, BC; P = 0.031,
BE; P = 0.007). Dexmedetomidine (P < 0.001) addition
increased the nociceptive block duration significantly in
comparison with the clonidine and epinephrine added
groups (Figure 6).
Complete recovery was determined in the rats that
were included in the study without any neurologic deficit
that could be clinically detected.

160
140
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100
80
60
40
20
0

Proprioceptive block durations
131*
105#

117*

82

Group B

Group BD

Group BC

Group BE

Figure 4. Proprioceptive block durations of groups. (*):
Statistically significant compared to group B (P < 0.05), (#):
Statistically significant compared to group BD (P < 0.05).
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Motor block durations
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Figure 5. Motor block durations of groups. (*): Statistically
significant compared to group B (P < 0.05), (#): Statistically
significant compared to group BD (P < 0.05).

Figure 6. Nociceptive block durations of groups. (*): Statistically
significant compared to group B (P < 0.05), (#): Statistically
significant compared to group BD (P < 0.05).

3.1. RT-PCR results
While the proportioning carried out showed that
the SCN9A gene expression of the Na channel was
100% in the group to which epinephrine was added
as adjuvant, it was determined to be 50% in groups to
which dexmedetomidine and clonidine were added. It
was determined to be 50% for the group to which pure
bupivacaine was administered (Figure 7A). TRPM2 gene
expression of the Ca+2 channel was high in groups to which
pure bupivacaine was administered and dexmedetomidine
and clonidine were added as adjuvants; it was determined
to be normal in the group to which epinephrine was added
(Figure 7B). TRPM4 gene expression of the Ca+2 channel
was determined to be normal in the group to which pure
bupivacaine was administered and epinephrine was added

as adjuvant, it was determined to be high in the group to
which dexmedetomidine was added and it was found to
be at the same ratio in the group to which clonidine was
added (Figure 7C). TRPM7 gene expression of the Ca+2
channel was determined to be 50% lower in the group
to which pure bupivacaine was administered; it was also
determined to be low in groups to which dexmedetomidine
and clonidine were added as adjuvants, whereas it was
found to be normal in the group to which epinephrine was
added (Figure 7D).

SCN9A

A
High

16.7%

Group B

50%

33.%3
16.7%

Group BD

C
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High

100%

Normal

83.%3

33.%3
16.7%
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0%

0%

16.7%

0% 0%
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Group BC

33.%3
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Group B
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33.%3
33.%3 33.%3 33.%3
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0%

16.7%
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Figure 7. Expression levels of target genes in groups.
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TRPM7
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83.3
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D
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66.7%
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TRPM4
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TRPM2

B

Normal

100%
50%
33.%3

4. Discussion
This randomized, blinded study examined the effects of
epinephrine, dexmedetomidine, and clonidine added as
adjuvants to bupivacaine in the sciatic nerve block of rats.
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16.7%
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Before the under epineural injection of local anesthetics,
intraperitoneal ketamine was use for the surgical
procedure. The local anesthetics were injected after full
recovery from the ketamine anesthesia and previous
studies used the same procedure with isoflurane (20,21).
Our results indicate that in all animal groups administered
adjuvants the sensory and motor block durations increased
and the block onset time decreased compared to the group
that received only bupivacaine. Brummett et al. (21) have
reported that 0.005% dexmedetomidine with the addition
of 0.5% bupivacaine increases sensory and motor block
times. Another study reported that ropivacaine added to
dexmedetomidine is more likely to cause a sensory block
than a motor block (22). Dexmedetomidine increased
both the sensory and the motor block in our study, but
the increase in the sensory block was greater. This is in
accordance with normal nerve conduction physiology.
Dexmedetomidine can be a useful adjuvant to add to
local anesthetics during the postoperative period to
provide analgesia without affecting mobilization. The
perineural administration of dexmedetomidine in
humans has not been approved by the Food and Drug
Administration (22). On the other hand, there have been
no reports of neurotoxicity. Clinical data have shown
that no neurotoxicity is observed in the sciatic nerve
block of rats when high doses of dexmedetomidine are
administered alone or in combination with bupivacaine
(21). According to our literature review, there has
been no study in which the effects of clonidine and
dexmedetomidine were compared in the perineural model
and no comparison with epinephrine. Recent studies have
shown that adding dexmedetomidine and clonidine as
adjuvants to bupivacaine provides adequate anesthesia and
postoperative analgesia compared to fentanyl in caesarean
sections (23) and that the addition of dexmedetomidine to
epidural bupivacaine can be advantageous with respect to
the increased duration of motor and sensory blockade and
arousable sedation (24).
Kanazi et al. (25) examined the effects of bupivacaine
added to a low dose of dexmedetomidine or clonidine in
spinal anesthesia and showed that both adjuvants decrease
block onset time and increase the motor and sensory block
times, which is in accordance with our study. Even though
it has been shown in many studies that clonidine increases
the anesthesia and analgesia times in peripheral nerve
blocks, it has been reported that this effect is less distinct
when combined with long-acting anesthetics (26–28).
Another study has suggested a more effective blockade by
clonidine in C-fibers, which was more effective than that
in Aα-fibers in rat sciatic nerve models (29). As is known
through transmission physiology, C-fibers are responsible
for the sensations of pain and heat, whereas Aα-fibers are
responsible for motor transmission. Knowing this, we can
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explain the reason for the longer sensory block time in the
group that received the addition of clonidine compared
to the motor block time. Recent studies have shown that
intrathecal dexmedetomidine is associated with prolonged
motor and sensory block compared to clonidine, fentanyl,
or bupivacaine alone (30) and that dexmedetomidine
added to intrathecal bupivacaine produces longer
postoperative analgesia than 50 µg of clonidine among
those undergoing lower limb surgery (31). In our study,
we used perineural administration; however, the results
match those of previous studies.
Kroin et al. (32) have shown that clonidine and
epinephrine added to the sciatic nerve block with
lidocaine increase the duration of analgesia and that the
effect of clonidine on the nerve block is not only through
α receptors. Even though dexmedetomidine, which is also
an α2 agonist, has effects similar to those of clonidine,
the fact that it causes longer sensory and motor blocks
can be explained by the fact that its selectivity to α2
receptors is eight times greater (33). Still, more studies that
compare these two α2 agonists are needed. In our study,
compared to the group that received just bupivacaine,
epinephrine (1/200,000) decreased the block onset time
and increased the sensory and motor block durations of
the group to which it was added. Another study showed
that bupivacaine added to epinephrine and bicarbonate
decreased the block onset time and similarly increased
the sensory and motor block times in the sciatic nerve
block of rats (34). Sinnott et al. (35) examined the
mechanisms whereby epinephrine potentializes lidocaine
in peripheral nerve blocks and reported that the addition
of epinephrine increased the sciatic nerve block time while
increasing the analgesic quality. There are two advantages
to the addition of epinephrine in making a block. First,
the plasma concentration of the local anesthetic is
decreased, thereby decreasing the risk of systemic toxicity.
Second, the block quality and time are increased. Many
anesthetists accept that epinephrine increases the local
anesthetic time via a vasoconstrictive effect. It excites the
α-adrenoreceptors in the neural veins, thus decreasing
blood flow and the absorption of lidocaine from the
nerves by causing vascular smooth muscle constriction
(36). Apart from its vasoconstriction effect, epinephrine
can also potentialize the effects of local anesthetics via
its pharmacodynamic effects on nerve membranes. The
activation of adrenoreceptors can be affected by various
factors, such as Na+, Cl– channels, and Na-K pump that
can regulate excitability (37). Partridge (38) administered
anesthetics to the rat sciatic nerve topically and evaluated
the blood flow using laser Doppler. The results showed that
epinephrine causes more vasoconstriction when added to
the local anesthetic than by itself. This effect decreases
the block onset time and increases the block duration. It
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should not be forgotten that the feeding of nerve fibers
can be disrupted in the case of intrafascicular injection.
Selander et al. (39) have shown that the nerve damage
caused by the intrafascicular injection of local anesthetic
can increase with the addition of epinephrine.
While the pain relieving effects of the analgesics that
target sodium channels are preserved, they also have an
increased potential for side effects. Mutation in the SCN9A
gene that encodes the Nav 1.7 sodium channel subtype
creates two different phenotypes. People with this mutation
either cannot feel the pain or have chronic familial pain
syndrome (40). Reimann et al. (41) carried out studies
on single nucleotide polymorphism (SNP) rs6746030
and determined that it changes pain sensitivity and pain
experience in common diseases, such as osteoarthritis
and spinal nerve root pain. They state that pharmacologic
substances that can modify the functions of SCN9A will be
beneficial in the treatment of diseases.
It has been shown that TRPM 2 activity increases
caspase 3, 8, 9, and, according to these data, TRPM2
channels facilitate an increase in cellular Ca+2 in response
to H2O2 and thus contribute to apoptotic cell death
induced by oxidants in endothelial cells. This means that
vascular endothelial cells can be protected from apoptotic
cell death by the downregulation of TRPM2 (42). The
increase in TRPM2 in all groups except the one that
received the addition of epinephrine can be interpreted
as a preindication of cell apoptosis. What is interesting
is that TRPM2 increased in the group that received only
bupivacaine, which shows that bupivacaine by itself
disrupts cellular integrity.
TRPM7 is activated by reactive oxygen and nitrogen
species. There is an important physiological balance
between TRPM2 and TRPM7 that is caused by oxidative
stress. The decrease in or the blocking of TRPM7 results
in a decrease in anoxia-induced cell death. Ca+2 intake,
the formation of reactive oxygen species, and anoxic cell
death decrease with the suppression of TRPM7 in cortical
neurons (43). A decrease in TRPM7 was observed in all
groups in our study except the group that received the
addition of epinephrine. TRPM7 decreased in the groups

in which TRPM2 increased, which is in accordance with
the aforementioned literature. It seems that while the cell
enters an apoptotic phase on the one hand, it tries to protect
itself against anoxic cell death as a reflexive response on
the other hand. Epinephrine is a natural catecholamine
that is secreted in the human body, and thus the minimal
change it causes in the Na+ and Ca+2 channel expression
ratios in the cell membrane cannot be explained only by a
vasoconstrictive effect. Results related to gene expression
in this study have shown that epinephrine has a more
protective effect at the cellular level than other adjuvants.
TRPM4 activation in physiological conditions causes
hyperpolarization and the flow of Na+ into the cell. In
pathological cases, TRPM4 activation causes Na+ loading. The
cell volume increases, which results in the rupture of the cell
membrane and thus irreversible cell necrosis (44). Gerzanich
et al. (45) examined the role of TRPM4 in progressive
secondary hemorrhage related to capillary fragmentation,
which is the most destructive mechanism in secondary injury
of the central nervous system (spinal cord injuries). Capillary
structural integrity has been retained in rats for which in vivo
TRPM4 gene suppression has been achieved. In addition,
secondary hemorrhage has been eliminated, a decrease in
lesion volume of one third to one fifth has been obtained,
and significant advancements in neurological functions have
been observed (45). In this study, significant results have not
been obtained regarding TRPM4.
In conclusion, the shortest onset of effect was observed
in the BC group in our study, whereas the longest block and
analgesic times were observed in the BD group. Clonidine
has a faster onset in peripheral nerve blocks, whereas
dexmedetomidine has a longer effect time. The increase in
the TRPM2 ratio in all groups except the BE group, which
is a preindication of cell apoptosis and oxidative stress,
and the decrease in the amount of TRPM7, which protects
cells against oxidative stress and anoxic cell death, are
noteworthy. We also observed that the use of bupivacaine
with epinephrine compared to bupivacaine alone results in
early block onset and a longer duration while being safer at
the cellular level. We think that our study will help inform
future studies.
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